173262-94-7 Usage
Description
2-amino-3-benzoyl-α-(1-propylthio)-benzeneacetamide is a chemical compound derived from Methyl Chloroacetate, which is a versatile compound used in various chemical and biochemical applications. 2-amino-3-benzoyl-α-(1-propylthio)-benzeneacetamide possesses unique structural features that make it potentially useful in different industries.
Uses
Used in Pharmaceutical Industry:
2-amino-3-benzoyl-α-(1-propylthio)-benzeneacetamide is used as an intermediate in the synthesis of pharmaceuticals for [application reason]. Its specific role in the synthesis process is due to its unique chemical properties that facilitate the creation of desired medicinal compounds.
Used in Chemical Synthesis:
In the chemical industry, 2-amino-3-benzoyl-α-(1-propylthio)-benzeneacetamide is used as a reagent for the synthesis of various compounds, including non-steroidal anti-inflammatory drugs (NSAIDs). Its role in this application is to provide a key building block for the development of these medications, which are widely used to treat pain and inflammation.
Used in Research and Development:
2-amino-3-benzoyl-α-(1-propylthio)-benzeneacetamide is also utilized in research and development settings as a compound of interest for further study. Its unique structure and properties make it a valuable candidate for exploring new chemical reactions and potential applications in various fields.
Check Digit Verification of cas no
The CAS Registry Mumber 173262-94-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,3,2,6 and 2 respectively; the second part has 2 digits, 9 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 173262-94:
(8*1)+(7*7)+(6*3)+(5*2)+(4*6)+(3*2)+(2*9)+(1*4)=137
137 % 10 = 7
So 173262-94-7 is a valid CAS Registry Number.
173262-94-7Relevant articles and documents
Topically administrable compositions containing 3-benzoylphenylacetic acid derivatives for treatment of ophthalmic inflammatory disorders
-
, (2008/06/13)
Novel ester and amide derivatives of 3-benzoylphenylacetic acid are disclosed. The use of these novel derivatives and certain known derivatives in topically administrable compositions for the treatment of ophthalmic inflammatory disorders is also disclosed.
